Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121682 | SCV000228255 | likely benign | not specified | 2015-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000988295 | SCV000290272 | likely benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001171105 | SCV000319511 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001573614 | SCV000520856 | likely benign | not provided | 2021-03-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23578328, 26708639, 17662764, 21457232, 24728327, 28074886, 28387797, 18593716) |
Center for Human Genetics, |
RCV000660161 | SCV000782155 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988295 | SCV001137963 | benign | Adams-Oliver syndrome 5 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171105 | SCV001333783 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-12-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000988295 | SCV002554440 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269857 | SCV002554441 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121682 | SCV004038990 | likely benign | not specified | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573614 | SCV004162028 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | NOTCH1: BS1 |
ARUP Laboratories, |
RCV001573614 | SCV004564886 | likely benign | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001573614 | SCV005228683 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000121682 | SCV000085880 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573614 | SCV001799771 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001573614 | SCV001809765 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001573614 | SCV001959023 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573614 | SCV001972799 | likely benign | not provided | no assertion criteria provided | clinical testing |